Bio-Techne (TECH) Interest & Investment Income (2009 - 2026)
Bio-Techne (TECH) posted quarterly Interest & Investment Income of $981000.0 for Q1 2026, down 4.39% year-over-year from $1.0 million in Q1 2025, and up 9.36% quarter-over-quarter from $897000.0 in Q4 2025.
Powered by 
Analysis
Bio-Techne (TECH) Interest & Investment Income (2009 - 2026) Analysis & Trends
Bio-Techne's Interest & Investment Income history runs 18 years deep, the most recent figure standing at $981000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 4.39% year-over-year to $981000.0; the TTM figure through Mar 2026 stood at $3.4 million (down 18.34% YoY), while the FY2025 annual figure was $3.9 million, up 16.94% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $981000.0, up from $897000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.3 million in Q4 2024, with the low at $168000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $905000.0 (2024), against an average of $813117.6.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 479.76% in 2023, then sank 35.36% in 2025.
- Bio-Techne's Interest & Investment Income stood at $968000.0 in 2022, then declined by 15.7% to $816000.0 in 2023, then surged by 65.2% to $1.3 million in 2024, then plunged by 33.46% to $897000.0 in 2025, then gained by 9.36% to $981000.0 in 2026.
- Business Quant data shows TECH's Interest & Investment Income at $981000.0 in Q1 2026, $897000.0 in Q4 2025, and $971000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 1.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Mar 31, 2026 | 981,000.00 |
| Dec 31, 2025 | 897,000.00 |
| Sep 30, 2025 | 971,000.00 |
| Jun 30, 2025 | 585,000.00 |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 926,000.00 |
| Jun 30, 2024 | 905,000.00 |
| Mar 31, 2024 | 712,000.00 |
| Dec 31, 2023 | 816,000.00 |
| Sep 30, 2023 | 890,000.00 |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 974,000.00 |
| Dec 31, 2022 | 968,000.00 |
| Sep 30, 2022 | 433,000.00 |
| Jun 30, 2022 | 188,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 193,000.00 |